TABLE 2

FROM:

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias

J M Burke, P C Caron, E B Papadopoulos, C R Divgi, G Sgouros, K S Panageas, R D Finn, S M Larson, R J O'Reilly, D A Scheinberg and J G Jurcic

Table 2. Pharmacokinetics and biodistribution of ¹³¹I-M195

	Marrow		Liver		Spleen		Whole body t1/2 (h)
	% ID/g a	t 1/2 (h)	% ID	t 1/2 (h)	% ID	t 1/2 (h)
All patients (n=8)	0.0110.002	5919	7.23.5	3812	ND	ND	5613
AML (n=3)	0.010	5931	10.04.4	3111	ND	ND	5212
CML (n=5)	0.0120.003	5911	5.51.6	4213	3.70.8	369	5814

 Values are shown as meanss.d. ND=not done.

^a % ID/g was estimated by extrapolation to time of injection for marrow.